|
The surgical issue questionnaire was reviewed for potential causes of the reported issue.Based on this review, implanting the device after the expiration date, not prepping the surface of the skin with an antiseptic solution, not irrigating the incision site with an antibiotic solution before closure, improperly closing the surgical site, multiple tunneling attempts, using inappropriate tools, and not prescribing antibiotics pre-operatively have been ruled out.Additionally, the patient touching or picking at the wound, the device being implanted off-label, and the patient having contraindicating conditions have been ruled out.A curonix representative conducted a review of sterilization and packaging records for the respective product lot; curonix has confirmed that the product was delivered sterile, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.The stimulator is used to treat pain.The cause of the impaired healing is unknown.The investigation findings do not lead to a clear conclusion about the cause of the reported issue.Therefore, the conclusion has been selected as unable to determine the root cause.Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in surgical issues.Surgical issue rates remain acceptably low; thus, a capa is not required at this time.Surgical issue rates will continue to be tracked and trended.
|
|
The patient reported impaired healing at the receiver site.Antibiotics were prescribed and as of on (b)(6) 2026, the patient reported significant improvement in wound healing.Additionally, the patient reported significant improvement with >90% pain relief.As of on (b)(6) 2026, the wound is closed, the patient completed their antibiotics and continues to use the neurostimulator and reported significant improvement in knee pain.No further issues have been reported.
|